Vertex Pharmaceuticals is a global biotechnology company that focuses on developing and commercializing innovative therapies for serious diseases. The company has a strong emphasis on research and development (R&D) and has made significant strides in the treatment of cystic fibrosis (CF). Vertex's strategic focus on specialized, high-impact therapies has enabled it to carve out a niche in the biopharmaceutical industry. However, the company faces challenges such as high R&D costs, regulatory hurdles, and competition from other biotech firms. As Vertex looks to expand its pipeline and enter new therapeutic areas, it must navigate these challenges while leveraging its strengths in innovation and scientific expertise.